METABOLIC SYNDROME – THE "SILENT KILLER", A CONTINUING CHALLENGE
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 4
Abstract
Metabolic syndrome, also known as dysmetabolic/plurimetabolic syndrome, X syndrome, insulinresistance syndrome or deadly quartet is an aggregate of interrelated metabolic abnormalities that occur with a higher prevalence in people with insulinresistance or with compensatory hyperinsulinism and identifies subjects who are at risk for developing type 2 diabetes and cardiovascular disease. In addition, individuals with metabolic syndrome are at increased risk of developing polycystic ovarian syndrome, non-alcoholic fatty liver, gallstones (cholesterol stones), sleep apnea, asthma and some forms of cancer.
Authors and Affiliations
Ecaterina Daniela Popescu, Diana Clenciu, Mihaela Vladu, Sigina Gîrgavu
Keywords
Related Articles
- EP ID EP150544
- DOI -
- Views 89
- Downloads 0
ADVANCED GLYCATION END PRODUCTS MEASURED BY AGE READER IN A GROUP OF PATIENTS WITH OBESITY
Background and Aim: Skin autofluorescence (AF) is a method used to detect the accumulation of Advanced Glycation End Products (AGEs) in skin collagen using AGE Reader. AGEs accumulation is favorised by chronic hype...
CORRELATIONS BETWEEN PRO-INFLAMMATORY MARKERS AND GLYCATED HEMOGLOBIN IN TYPE 2 DIABETES PATIENTS
Background and Aim. Markers of inflammation are predictive of diabetic macrovascular complications. In type 2 diabetes, inflammation might be responsible for enhancing insulin resistance and may contribute to the reducti...
THE VALUE OF DIFFERENT ANTHROPOMETRIC VARIABLES IN ASSESSING CARDIOMETABOLIC RISK
Objective. To investigate which anthropometric parameter best correlates with modifications in blood glucose and blood pressure (BP). Material and method. 135 subjects were included in the study. We measured weight, heig...
Weight Gain With Insulin Therapy In Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs
Type 2 diabetes mellitus is a disease with progressive beta-cell decline and most patients will require insulin therapy to control their glycemic homeostasis. The aims of this study is to estimate the weight gain associa...
SODIUM-GLUCOSE TRANSPORTER 2 INHIBITION – A POTENTIAL OPTION FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS
Glucose homeostasis is maintained by the balanced actions of glucose absorption, gluconeogenesis, glycogenolysis, glucose consumption, glucose excretion and glucose reabsorption. The human kidney is involved in glucose r...